Investors
|
|||
|
Corporate Profile OSI Pharmaceuticals is committed to “shaping medicine and changing lives” by developing and commercializing high-quality and novel pharmaceutical products that extend life or improve the quality of life for patients with cancer, diabetes, and obesity. We specialize in the discovery and development of innovative molecular targeted therapies that address significant unmet medical needs, and strive to turn pioneering science into breakthrough therapies for patients suffering from life-threatening diseases. |
|||
| Stock Quote | |
|---|---|
| OSIP (Common Stock) | |
| Exchange | NASDAQ |
| Price | $34.17 |
| Change (%) |  0.56 (1.61%) |
| Volume | 400,700 |
| As of 02/8/10 3:59 PM ET Minimum 20 minute delay |
|